Literature DB >> 24747228

Intelligent pharmaceuticals: beyond the tipping point.

P Honig1, S-M Huang2.   

Abstract

Confluences of key factors can transform apparently isolated or random events into trends. The ongoing and growing pressures facing the pharmaceutical industry have "tipped" the industry toward a new direction in the choice of which new medicines to develop and how to develop them. We examine the factors that are at the tipping point.

Mesh:

Substances:

Year:  2014        PMID: 24747228     DOI: 10.1038/clpt.2014.32

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  3 in total

1.  Bioinnovation Enterprise: An engine driving breakthrough therapies.

Authors:  S A Waldman; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2016-01       Impact factor: 6.875

2.  Managing Innovation to Maximize Value Along the Discovery-Translation-Application Continuum.

Authors:  S A Waldman; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2016-11-21       Impact factor: 6.875

3.  Overcoming the Declining Trends in Innovation and Investment in Cardiovascular Therapeutics: Beyond EROOM's Law.

Authors:  Gail A Van Norman
Journal:  JACC Basic Transl Sci       Date:  2017-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.